Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Proteomics of endometrial cancer diagnosis, treatment, and prognosis
Author: Mittal, P.
Klingler-Hoffmann, M.
Arentz, G.
Zhang, C.
Kaur, G.
Oehler, M.
Hoffmann, P.
Citation: Proteomics - Clinical Applications, 2016; 10(3):217-229
Publisher: Wilely
Issue Date: 2016
ISSN: 1862-8346
Statement of
Parul Mittal, Manuela Klingler-Hoffmann, Georgia Arentz, Chao Zhang, Gurjeet Kaur, Martin K. Oehler, and Peter Hoffmann
Abstract: This review discusses the current status of proteomics technology in endometrial cancer diagnosis, treatment and prognosis. The first part of this review focuses on recently identified biomarkers for endometrial cancer, their importance in clinical use as well as the proteomic methods used in their discovery. The second part highlights some of the emerging mass spectrometry based proteomic technologies that promise to contribute to a better understanding of endometrial cancer by comparing the abundance of hundreds or thousands of proteins simultaneously.
Keywords: Biomarker; Endometrial cancer
Rights: © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
RMID: 0030040101
DOI: 10.1002/prca.201500055
Appears in Collections:Molecular and Biomedical Science publications

Files in This Item:
File Description SizeFormat 
hdl_99849.pdfAccepted version1.05 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.